SEFULNESS OF HOMOEOPATHY IN ATOPIC DERMATITIS
Not Applicable
- Conditions
- Health Condition 1: L20- Atopic dermatitis
- Registration Number
- CTRI/2019/01/017074
- Lead Sponsor
- ATIONAL INSTITUTE OF HOMOEOPATHY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Cases suffering from atopic dermatitis diagnosed by UK Diagnostic crieteria(as per ICD L20.9
2. both sexes
3. giving written consent to participate in trial.
4 patients already undergoing regular oral/topical conventional therapy for AD can be recruited only if medications are stopped completely.
Exclusion Criteria
1.Patients who are too sick for consultation
2 unwilling to take part and not giving written consent to join the study.
3.diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life -threatning illness affecting quality of life.
4.pregnancy and lactation
5.substance abuse and or dependence
6 undergoing homoeopathic treatment for any chronic disease with in last 6months.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome <br/ ><br>POSCORAD[18] index is a scale to assess the severity of AD , includes two <br/ ><br>parameter one is intensity and other is areas involvedTimepoint: baseline and three months
- Secondary Outcome Measures
Name Time Method (1) Dermatological Life Quality index <br/ ><br>The scoring of each question <br/ ><br>Very much scored 3 <br/ ><br>A lot scored 2 <br/ ><br>A little scored 1 <br/ ><br>Not at all scored 0 <br/ ><br>Not relevant scored 0 <br/ ><br>Question 7 , â??prevented work or studying scored 3 <br/ ><br> <br/ ><br>(2) ATOPIC DERMATITIS BURDEN SCALE FOR ADULTS[22] <br/ ><br> assesed as <br/ ><br>never, rarely, sometimes, often, very often and constantly. <br/ ><br>score is interpreted as follows: <br/ ><br>9.75 or below mild <br/ ><br>9.76 to 20.61 moderate <br/ ><br>20.62 to 33.52 or above severeTimepoint: baseline and three months